Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02044770 · ClinicalTrials.gov registry record

ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy

A clinical trial of Any Condition Requiring Surgical Treatment Via Colectomy, sponsored by Ethicon Endo-Surgery.

Completed
Registry status
29
Enrollment target
3
Study locations

NCT02044770 is a study of Any Condition Requiring Surgical Treatment Via Colectomy that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 29 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02044770, a study of Any Condition Requiring Surgical Treatment Via Colectomy, has completed, sponsored by Ethicon Endo-Surgery.

COMPLETED
Registry status
29 participants
Enrollment target
3
Study locations

Study Summary

The primary objective of this clinical study is to describe the initial clinical experience with ENSEAL® G2 Articulating Tissue Sealer in laparoscopic colectomy, quantifying and/or qualifying how its articulation feature enables optimization of vessel sealing through improved access, approach, and visibility. This is an observational study of device usage being conducted to report initial experience with the ENSEAL ART device. It is not intended as hypothesis testing.

Study Locations (3)

Indiana

  • Franciscan St. Francis Health - Indianapolis

New Jersey

  • Jersey Shore University medical Center - Neptune City

Ohio

  • The Christ Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-01
Est. Completion 2014-06

Sponsor

Ethicon Endo-Surgery

39 total trials

What the Registry Record Tells You About NCT02044770

The ClinicalTrials.gov registry entry for NCT02044770 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Any Condition Requiring Surgical Treatment Via Colectomy appearing as the primary indexed condition, and to 0 interventions.

NCT02044770 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Indiana, New Jersey, Ohio.

Frequently Asked Questions

What is clinical trial NCT02044770 about?

NCT02044770 is a clinical study titled "ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy". The primary objective of this clinical study is to describe the initial clinical experience with ENSEAL® G2 Articulating Tissue Sealer in laparoscopic colectomy, quantifying and/or qualifying how its articulation feature enables optimization of vessel sealing through improved access, approach, and v...

What is the current status of trial NCT02044770?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2014-01. Estimated completion is 2014-06.

What conditions does trial NCT02044770 study?

This clinical trial studies the following conditions: Any Condition Requiring Surgical Treatment Via Colectomy.

Who is sponsoring clinical trial NCT02044770?

This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02044770 being conducted?

This trial has 3 study locations across Indiana, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.